These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12848966)

  • 1. B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications.
    Tuscano JM; Harris GS; Tedder TF
    Autoimmun Rev; 2003 Mar; 2(2):101-8. PubMed ID: 12848966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity.
    Mackay F; Mackay CR
    Trends Immunol; 2002 Mar; 23(3):113-5. PubMed ID: 11864827
    [No Abstract]   [Full Text] [Related]  

  • 3. BAFF: a novel therapeutic target for autoimmunity.
    Kalled SL
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1005-10. PubMed ID: 12186259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The buzz about BAFF.
    Vaux DL
    J Clin Invest; 2002 Jan; 109(1):17-8. PubMed ID: 11781346
    [No Abstract]   [Full Text] [Related]  

  • 5. Determinations of B cell fate in immunity and autoimmunity.
    Noelle RJ; Erickson LD
    Curr Dir Autoimmun; 2005; 8():1-24. PubMed ID: 15564715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 7. TNF ligands and receptors in autoimmunity: an update.
    Mackay F; Kalled SL
    Curr Opin Immunol; 2002 Dec; 14(6):783-90. PubMed ID: 12413530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    Baert L; Manfroi B; Casez O; Sturm N; Huard B
    J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity.
    Fujimoto M; Sato S
    J Dermatol Sci; 2007 Apr; 46(1):1-9. PubMed ID: 17223015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system.
    Tedder TF; Poe JC; Fujimoto M; Haas KM; Sato S
    Curr Dir Autoimmun; 2005; 8():55-90. PubMed ID: 15564717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BAFF/APRIL system: an important player in systemic rheumatic diseases.
    Mackay F; Sierro F; Grey ST; Gordon TP
    Curr Dir Autoimmun; 2005; 8():243-65. PubMed ID: 15564724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders.
    Kalled SL; Ambrose C; Hsu YM
    Expert Opin Ther Targets; 2003 Feb; 7(1):115-23. PubMed ID: 12556207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of targeting B cell receptor complex to treat B-cell derived autoimmune diseases and lymphomas.
    Adem J; Eray M; Eeva J; Nuutinen U; Pelkonen J
    Mol Immunol; 2017 Aug; 88():135-137. PubMed ID: 28644972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new perspective on therapies involving B-cell depletion in autoimmune diseases.
    Al-Hawary SIS; Jasim SA; Hjazi A; Ullah H; Bansal P; Deorari M; Sapaev IB; Ami AA; Mohmmed KH; Abosaoda MK
    Mol Biol Rep; 2024 May; 51(1):629. PubMed ID: 38717637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic roles of B cells in human autoimmunity; insights from the clinic.
    Martin F; Chan AC
    Immunity; 2004 May; 20(5):517-27. PubMed ID: 15142521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signalling pathways in B cells: implications for autoimmunity.
    Dörner T; Lipsky PE
    Curr Top Microbiol Immunol; 2006; 305():213-40. PubMed ID: 16724808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.